• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种高危型人乳头瘤病毒E6蛋白中混杂表位的预测:一种计算方法

Prediction of promiscuous epitopes in the e6 protein of three high risk human papilloma viruses: a computational approach.

作者信息

Subramanian Nirmala, Chinnappan Sudandiradoss

机构信息

Bioinformatics Division, School of Biosciences and Technology, VIT University, Vellore, India.

出版信息

Asian Pac J Cancer Prev. 2013;14(7):4167-75. doi: 10.7314/apjcp.2013.14.7.4167.

DOI:10.7314/apjcp.2013.14.7.4167
PMID:23991971
Abstract

A najor current challenge and constraint in cervical cancer research is the development of vaccines against human papilloma virus (HPV) epitopes. Although many studies are done on epitope identification on HPVs, no computational work has been carried out for high risk forms which are considered to cause cervical cancer. Of all the high risk HPVs, HPV 16, HPV 18 and HPV 45 are responsible for 94% of cervical cancers in women worldwide. In this work, we computationally predicted the promiscuous epitopes among the E6 proteins of high risk HPVs. We identified the conserved residues, HLA class I, HLA class II and B-cell epitopes along with their corresponding secondary structure conformations. We used extremely precise bioinformatics tools like ClustalW2, MAPPP, NetMHC, EpiJen, EpiTop 1.0, ABCpred, BCpred and PSIPred for achieving this task. Our study identified specific regions 'FAFR(K)DL' followed by 'KLPD(Q)LCTEL' fragments which proved to be promiscuous epitopes present in both human leukocyte antigen (HLA) class I, class II molecules and B cells as well. These fragments also follow every suitable character to be considered as promiscuous epitopes with supporting evidences of previously reported experimental results. Thus, we conclude that these regions should be considered as the important for design of specific therapeutic vaccines for cervical cancer.

摘要

宫颈癌研究当前面临的一个主要挑战和限制是针对人乳头瘤病毒(HPV)表位开发疫苗。尽管针对HPV的表位鉴定已开展了许多研究,但对于被认为会引发宫颈癌的高危型HPV,尚未进行过计算方面的工作。在所有高危型HPV中,HPV 16、HPV 18和HPV 45导致了全球94%的女性宫颈癌。在这项工作中,我们通过计算预测了高危型HPV的E6蛋白中的多聚表位。我们确定了保守残基、HLA I类、HLA II类和B细胞表位及其相应的二级结构构象。为完成这项任务,我们使用了极为精确的生物信息学工具,如ClustalW2、MAPPP、NetMHC、EpiJen、EpiTop 1.0、ABCpred、BCpred和PSIPred。我们的研究确定了特定区域“FAFR(K)DL”以及随后的“KLPD(Q)LCTEL”片段,这些片段被证明是存在于人白细胞抗原(HLA)I类、II类分子以及B细胞中的多聚表位。这些片段还符合被视为多聚表位的所有合适特征,并得到了先前报道的实验结果的支持证据。因此,我们得出结论,这些区域对于设计针对宫颈癌的特异性治疗疫苗至关重要。

相似文献

1
Prediction of promiscuous epitopes in the e6 protein of three high risk human papilloma viruses: a computational approach.三种高危型人乳头瘤病毒E6蛋白中混杂表位的预测:一种计算方法
Asian Pac J Cancer Prev. 2013;14(7):4167-75. doi: 10.7314/apjcp.2013.14.7.4167.
2
HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach.基于人群中 HLA-A 位点分布的 HPV-16 E6 和 E7 蛋白 T 细胞表位预测分析:一种计算机方法。
Vaccine. 2013 Apr 26;31(18):2289-94. doi: 10.1016/j.vaccine.2013.02.065. Epub 2013 Mar 13.
3
HLA class I binding promiscuity of the CD8 T-cell epitopes of human papillomavirus type 16 E6 protein.人乳头瘤病毒16型E6蛋白的CD8 T细胞表位的HLA I类结合混杂性
J Virol. 2007 Feb;81(3):1412-23. doi: 10.1128/JVI.01768-06. Epub 2006 Nov 15.
4
Identification of epitopes in Indian human papilloma virus 16 E6: a bioinformatics approach.利用生物信息学方法鉴定印度人乳头瘤病毒 16 型 E6 表位。
J Virol Methods. 2011 Oct;177(1):26-30. doi: 10.1016/j.jviromet.2011.06.006. Epub 2011 Jun 15.
5
Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China.中国西南地区16型人乳头瘤病毒E6和E7变体对T细胞和B细胞表位影响的鉴定
Immunol Lett. 2017 Jan;181:26-30. doi: 10.1016/j.imlet.2016.09.013. Epub 2016 Sep 28.
6
CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes.健康供体中针对人乳头瘤病毒18型E6转化蛋白的CD4 + T细胞免疫:混杂的天然加工表位的鉴定
Eur J Immunol. 2005 Mar;35(3):806-15. doi: 10.1002/eji.200425699.
7
T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.在与宫颈癌相关的16型人乳头瘤病毒E6转化蛋白中鉴定出的辅助性T细胞表位。
Viral Immunol. 1999;12(4):297-312. doi: 10.1089/vim.1999.12.297.
8
Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.基于 HPV58 分离株 E6 和 E7 保守蛋白序列设计表位疫苗:一种免疫信息学方法。
Interdiscip Sci. 2018 Jun;10(2):251-260. doi: 10.1007/s12539-016-0184-5. Epub 2016 Sep 17.
9
Different methods of identifying new antigenic epitopes of human papillomavirus type 16 E6 and E7 proteins.鉴定人乳头瘤病毒16型E6和E7蛋白新抗原表位的不同方法。
Clin Diagn Lab Immunol. 2004 Sep;11(5):889-96. doi: 10.1128/CDLI.11.5.889-896.2004.
10
Prediction of epitopes and structural properties of Iranian HPV-16 E6 by bioinformatics methods.利用生物信息学方法预测伊朗人乳头瘤病毒16型E6蛋白的表位和结构特性
Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):602-6.

引用本文的文献

1
Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.应用免疫信息学和 MD 模拟分析技术从 HPV 型 16 和 18 的 E6 和 E7 癌蛋白预测用于治疗性疫苗设计的抗原肽。
Front Immunol. 2018 Dec 19;9:3000. doi: 10.3389/fimmu.2018.03000. eCollection 2018.
2
Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18.用于生产针对16型和18型人乳头瘤病毒疫苗的L1蛋白的表位设计
Bioinformation. 2017 Mar 31;13(3):86-93. doi: 10.6026/97320630013086. eCollection 2017.
3
Classification epitopes in groups based on their protein family.
根据表位的蛋白质家族将其分类成组。
BMC Bioinformatics. 2015;16 Suppl 19(Suppl 19):S7. doi: 10.1186/1471-2105-16-S19-S7. Epub 2015 Dec 16.